As metabolic syndrome emerges as a global health challenge, modern dietary habits—high in calories and low in fiber—are leading to widespread issues such as obesity, hyperglycemia, and dyslipidemia. These metabolic disturbances are often accompanied by gut microbiota imbalances, further exacerbating health risks.

In response to this pressing issue, the Taichung District Agricultural Research and Extension Station (TDARES) has developed a novel functional synbiotic that combines probiotics and prebiotics. This innovative formulation aims to restore gut microbiota balance, improve metabolic disorders, and pave the way for advanced nutritional and medical applications.

Breakthrough in Functional Ingredients: ASEC-Processed Job’s Tears as a Potent Prebiotic

At the core of this innovation is the advanced steam extrusion cooking (ASEC) technology applied to Job’s tears (Coix lacryma-jobi). Researchers discovered that this proprietary processing technique significantly increases the resistant starch content in Job’s tears, making it a cost-effective and potent prebiotic ingredient.

The polysaccharides extracted from Job’s tears have been shown to selectively promote the growth of beneficial gut bacteria, particularly Bifidobacteria (Bifidus spp.) and Akkermansia muciniphila (AKK), a next-generation probiotic known for its role in gut barrier integrity, inflammation reduction, and metabolic health improvement.

Animal Studies Validate Metabolic Benefits

Preclinical trials in high-fat diet-fed mice demonstrated significant metabolic improvements over eight weeks:

• Reduced blood lipid levels, cholesterol, and hepatic fat accumulation in the synbiotic-treated group compared to controls.
• Suppression of gut microbiota dysbiosis induced by high-fat, high-cholesterol diets.
• Enhanced gut microbial diversity and structural stability.
• Prevention of excessive weight gain, reduced fat accumulation, and improved insulin sensitivity.

Notably, this functional synbiotic formulation outperformed conventional lipid-lowering medications, presenting a natural and effective alternative for managing metabolic disorders.

Strategic Market Potential and Future Applications

According to TDARES Deputy Director Chen Yu-Hsin, this technology’s versatility is a key highlight. Beyond restoring gut microbiota balance, it offers a scientifically validated approach to combating metabolic disorders associated with dietary habits. By combining Job’s tears polysaccharides with patented probiotic strains, this functional synbiotic is positioned to address obesity, fatty liver disease, and lipid dysregulation while rebuilding a healthy gut microbiome.

The broad application potential of this innovation includes:

• Customized functional food products tailored to consumer preferences.
• Health supplement formulations for metabolic health management.
• Regulatory approval as a certified health food product to enhance market adoption.

As the global probiotics and prebiotics market continues to expand, this pioneering synbiotic solution is expected to gain significant consumer interest and drive commercial growth. With its scientifically backed efficacy and cost-effective production, this technology offers a promising and scalable approach to metabolic syndrome prevention and management.

Resource:《新創動態》益生菌加益生質調整腸道菌群 改善代謝症候群